EP0552576A1 - Process for producing collagen fibres - Google Patents
Process for producing collagen fibres Download PDFInfo
- Publication number
- EP0552576A1 EP0552576A1 EP92403501A EP92403501A EP0552576A1 EP 0552576 A1 EP0552576 A1 EP 0552576A1 EP 92403501 A EP92403501 A EP 92403501A EP 92403501 A EP92403501 A EP 92403501A EP 0552576 A1 EP0552576 A1 EP 0552576A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- collagen
- process according
- collagen fibers
- strong base
- alkaline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08H—DERIVATIVES OF NATURAL MACROMOLECULAR COMPOUNDS
- C08H1/00—Macromolecular products derived from proteins
- C08H1/06—Macromolecular products derived from proteins derived from horn, hoofs, hair, skin or leather
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
Definitions
- the present invention relates to a new process for preparing collagen fibers having a high hemostatic power.
- Collagen is a very abundant protein in the connective tissues of mammals. It is in particular the main component of the skin. This is how animal skins represent an important source of collagen.
- the technique of extracting collagen from animal skins has been well known for many years. It consists in preparing the skins by eliminating the undesirable materials such as the hair, the epidermis and the flesh by physical treatments, such as for example rinsing with water, mechanical treatments, such as for example fleshing and refitting and chemical treatments, such as liming with a mixture of lime and sodium sulphide, then deliming with a mixture of ammonium chloride and sodium metabisulphite and finally extraction of the collagen with an organic acid, preferably an organic acid chlorinated as recommended by French patent FR-A-1568 829.
- the process for preparing gels and native collagen fibers from animal skins consists in eliminating non-collagenic substances, carrying out an alkaline chemical treatment with a strong base, at a concentration of the order of 1N, at a temperature not exceeding 30-32 ° C, for 0.5 to 1.5 hours, then neutralize the medium, extract the collagen with an organic acid, preferably a chlorinated organic acid and if necessary to obtain the collagen fibers, lyophilize the gel obtained after dilution and purification, said lyophilized gel consisting of collagen fibers.
- the alkaline chemical treatment consists of the action of sodium hydroxide or potassium hydroxide at a concentration of the order of 1N, at room temperature (18-25 ° C), for approximately 1 hour.
- Another subject of the invention relates to gels and fibers of native collagen obtained according to said process, as industrial products.
- the hemostatic properties of collagen are well known. However, surprisingly, it has been observed that the native collagen fibers obtained by the process according to the invention have a haemostatic power very much greater than the haemostatic power of the collagen fibers obtained by the processes known from the prior art.
- the haemostatic power of the various products was evaluated in vitro according to the method described by Rosy Eloy et al. in Journal of Biomedical Materials Research, Vol. 22, 149-157 (1988), on whole non-anticoagulated human blood from 3 different donors.
- the activation of hemostasis on contact with 50 mg (unless otherwise indicated in Table I below) of each of the products divided into 12 equal parts is evaluated by measuring the kinetics of generation of Fibrinopeptide A.
- the comparison of the different products between they are carried out by the method of scores assigned according to the activity rank of each product (from 3 for the most active product to 0 for the least active product) for each donor and at sampling times corresponding to the 3 rd , 4 th , 5 th and 6 th minutes.
- the collagen fibers obtained by the process according to the invention accelerate the kinetics of generation of Fibrinopeptide A and have a hemostatic power 1.5 to 2.5 times greater than collagen fibers obtained by a process. differing from that of the invention only by the absence of the alkaline treatment step.
- the method according to the invention is applicable to the production of collagen gels and collagen fibers, in particular in the form of compresses, which can be used in the field of dressings and in surgery as hemostatic contact agents and for controlling hemorrhages.
Abstract
Description
La présente invention concerne une nouveau procédé de préparation de fibres de collagène présentant un haut pouvoir hémostatique.The present invention relates to a new process for preparing collagen fibers having a high hemostatic power.
Le collagène est une protéine très abondante dans les tissus conjonctifs des mammifères. Il constitue notamment le composant principal de la peau. C'est ainsi que les peaux d'animaux représentent une source importante de collagène.Collagen is a very abundant protein in the connective tissues of mammals. It is in particular the main component of the skin. This is how animal skins represent an important source of collagen.
La technique d'extraction du collagène à partir des peaux d'animaux est bien connue depuis de longues années. Elle consiste à préparer les peaux en éliminant les matières indésirables comme les poils, l'épiderme et la chair par des traitements physiques, comme par exemple le rinçage à l'eau, des traitements mécaniques, comme par exemple l'écharnage et le refandage et des traitements chimiques, comme par exemple le chaulage par un mélange de chaux et de sulfure de sodium, puis déchaulage par un mélange de chlorure d'ammonium et de métabisulfite de sodium et enfin extraction du collagène par un acide organique, de préférence un acide organique chloré comme préconisé par le brevet français FR-A-1568 829.The technique of extracting collagen from animal skins has been well known for many years. It consists in preparing the skins by eliminating the undesirable materials such as the hair, the epidermis and the flesh by physical treatments, such as for example rinsing with water, mechanical treatments, such as for example fleshing and refitting and chemical treatments, such as liming with a mixture of lime and sodium sulphide, then deliming with a mixture of ammonium chloride and sodium metabisulphite and finally extraction of the collagen with an organic acid, preferably an organic acid chlorinated as recommended by French patent FR-A-1568 829.
Afin de conserver d'une part la structure hélicoïdale, d'autre part la structure moléculaire du collagène natif, les traitements physiques et chimiques doivent être effectués à une température ne dépassant pas 30 à 32°C comme préconisé par FR-A-1568 829 et dans des conditions d'alcalinité ou d'acidité contrôlées. On sait en effet par la demande de brevet français FR-A-2371475 que les télopeptides du collagène se trouvant aux extrémités des chaînes polypeptidiques sont hydrolysés par les substances alcalines, notamment lors d'un traitement par la soude à une concentration de 0,3 à 1N pendant 5 heures à 10 jours, la structure moléculaire du collagène se trouvant ainsi modifiée. On sait également par la demande de brevet européen EP-A-0081440 qu'un traitement alcalin prolongé, par exemple à pH 14 pendant 8 jours, conduit à une déréticulation du collagène, c'est-à-dire à la destruction de la structure hélicoïdale du collagène.In order to preserve on the one hand the helical structure, on the other hand the molecular structure of collagen native, physical and chemical treatments must be carried out at a temperature not exceeding 30 to 32 ° C as recommended by FR-A-1568 829 and under controlled alkalinity or acidity conditions. We know indeed from French patent application FR-A-2371475 that the collagen telopeptides found at the ends of the polypeptide chains are hydrolyzed by alkaline substances, in particular during treatment with sodium hydroxide at a concentration of 0.3 at 1N for 5 hours to 10 days, the molecular structure of collagen thus being modified. It is also known from European patent application EP-A-0081440 that a prolonged alkaline treatment, for example at pH 14 for 8 days, leads to a de-crosslinking of the collagen, that is to say to the destruction of the structure helical collagen.
On vient à présent de trouver qu'un traitement du collagène en milieu basique fort, à une concentration de l'ordre de 1N, pendant 0,5 à 1,5 heure et à une température ne dépassant pas 30-32°C, non seulement ne modifie pas la structure hélicoïdale du collagène ni sa structure moléculaire, mais permet d'obtenir des fibres de collagène natif qui présentent de façon inattendue, un pouvoir hémostatique supérieur au pouvoir hémostatique des fibres de collagène obtenues par les procédés connus de l'art antérieur.We have now found that a treatment of collagen in a strong basic medium, at a concentration of the order of 1N, for 0.5 to 1.5 hours and at a temperature not exceeding 30-32 ° C, not only does not modify the helical structure of the collagen nor its molecular structure, but makes it possible to obtain native collagen fibers which have, unexpectedly, a hemostatic power greater than the hemostatic power of the collagen fibers obtained by the methods known in the art prior.
Le procédé de préparation de gels et de fibres de collagène natif à partir de peaux animales selon l'invention consiste à éliminer les substances non collagéniques, procéder à un traitement chimique alcalin par une base forte, à une concentration de l'ordre de 1N, à une température ne dépassant pas 30-32°C, pendant 0,5 à 1,5 heure, puis neutraliser le milieu, extraire le collagène par un acide organique, de préférence un acide organique chloré et le cas échéant pour obtenir les fibres de collagène, lyophiliser le gel obtenu après dilution et purification, ledit gel lyophilisé étant constitué de fibres de collagène.The process for preparing gels and native collagen fibers from animal skins according to the invention consists in eliminating non-collagenic substances, carrying out an alkaline chemical treatment with a strong base, at a concentration of the order of 1N, at a temperature not exceeding 30-32 ° C, for 0.5 to 1.5 hours, then neutralize the medium, extract the collagen with an organic acid, preferably a chlorinated organic acid and if necessary to obtain the collagen fibers, lyophilize the gel obtained after dilution and purification, said lyophilized gel consisting of collagen fibers.
De façon avantageuse le traitement chimique alcalin consiste en l'action de la soude ou la potasse à une concentration de l'ordre de 1N, à la température ambiante (18-25°C), pendant environ 1 heure.Advantageously, the alkaline chemical treatment consists of the action of sodium hydroxide or potassium hydroxide at a concentration of the order of 1N, at room temperature (18-25 ° C), for approximately 1 hour.
Un autre objet de l'invention a trait aux gels et fibres de collagène natif obtenus selon ledit procédé, en tant que produits industriels.Another subject of the invention relates to gels and fibers of native collagen obtained according to said process, as industrial products.
Les propriétés hémostatiques du collagène sont bien connues. Cependant, de façon surprenante, on a observé que les fibres de collagène natif obtenues par le procédé selon l'invention possèdent un pouvoir hémostatique très nettement supérieur au pouvoir hémostatique des fibres de collagène obtenues par les procédés connus de l'art antérieur.The hemostatic properties of collagen are well known. However, surprisingly, it has been observed that the native collagen fibers obtained by the process according to the invention have a haemostatic power very much greater than the haemostatic power of the collagen fibers obtained by the processes known from the prior art.
On a préparé 2 lots de fibres de collagène par le procédé selon l'invention, c'est-à-dire par traitement du collagène par la soude 1N pendant une heure à 20°C, et on a déterminé leur pouvoir hémostatique par comparaison avec un produit de l'art antérieur constitué de collagène natif préparé selon un procédé ne différant de celui de l'invention que par l'absence de l'étape de traitement alcalin et commercialisé sous la dénomination PANGEN par la société Laboratoires FOURNIER.2 batches of collagen fibers were prepared by the process according to the invention, that is to say by treatment of the collagen with 1N sodium hydroxide for one hour at 20 ° C., and their hemostatic power was determined by comparison with a product of the prior art consisting of native collagen prepared according to a process differing from that of the invention only by the absence of the alkaline treatment step and marketed under the name PANGEN by the company Laboratoires FOURNIER.
Le pouvoir hémostatique des différents produits a été évalué in vitro selon la méthode décrite par Rosy Eloy et al. dans Journal of Biomedical Materials Research, Vol.22, 149-157 (1988), sur sang humain complet non anticoagulé de 3 donneurs différents. L'activation de l'hémostase au contact de 50 mg (sauf indication contraire dans le tableau I suivant) de chacun des produits divisés en 12 parties égales est évaluée par mesure de la cinétique de génération du Fibrinopeptide A. La comparaison des différents produits entre eux est réalisée par la méthode des scores attribués selon le rang d'activité de chacun des produits (de 3 pour le produit le plus actif à 0 pour le produit le moins actif) pour chaque donneur et à des temps de prélèvement correspondant aux 3ème, 4ème, 5ème et 6ème minutes.The haemostatic power of the various products was evaluated in vitro according to the method described by Rosy Eloy et al. in Journal of Biomedical Materials Research, Vol. 22, 149-157 (1988), on whole non-anticoagulated human blood from 3 different donors. The activation of hemostasis on contact with 50 mg (unless otherwise indicated in Table I below) of each of the products divided into 12 equal parts is evaluated by measuring the kinetics of generation of Fibrinopeptide A. The comparison of the different products between they are carried out by the method of scores assigned according to the activity rank of each product (from 3 for the most active product to 0 for the least active product) for each donor and at sampling times corresponding to the 3 rd , 4 th , 5 th and 6 th minutes.
Les scores totaux obtenus sont regroupés dans le tableau I suivant :
On a vérifié que le temps de coagulation d'un sang humain complet, en l'absence de fibres de collagène, est trois fois plus long qu'en présence du collagène des produits comparatifs.It has been verified that the coagulation time of whole human blood, in the absence of collagen fibers, is three times longer than in the presence of collagen of the comparative products.
Il ressort de ces résultats que les fibres de collagène obtenues par le procédé selon l'invention accélèrent la cinétique de génération du Fibrinopeptide A et présentent un pouvoir hémostatique 1,5 à 2,5 fois supérieur à des fibres de collagène obtenues par un procédé ne différant de celui de l'invention que par l'absence de l'étape de traitement alcalin.It appears from these results that the collagen fibers obtained by the process according to the invention accelerate the kinetics of generation of Fibrinopeptide A and have a hemostatic power 1.5 to 2.5 times greater than collagen fibers obtained by a process. differing from that of the invention only by the absence of the alkaline treatment step.
Le procédé selon l'invention est applicable à la fabrication de gels de collagène et de fibres de collagène, notamment sous forme de compresses, utilisables dans le domaine des pansements et en chirurgie comme agents hémostatiques de contact et pour le contrôle des hémorragies.The method according to the invention is applicable to the production of collagen gels and collagen fibers, in particular in the form of compresses, which can be used in the field of dressings and in surgery as hemostatic contact agents and for controlling hemorrhages.
Claims (6)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9200739 | 1992-01-24 | ||
FR9200739A FR2686612B1 (en) | 1992-01-24 | 1992-01-24 | PROCESS FOR THE PREPARATION OF COLLAGEN FIBERS. |
Publications (2)
Publication Number | Publication Date |
---|---|
EP0552576A1 true EP0552576A1 (en) | 1993-07-28 |
EP0552576B1 EP0552576B1 (en) | 1998-02-25 |
Family
ID=9425930
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP92403501A Expired - Lifetime EP0552576B1 (en) | 1992-01-24 | 1992-12-21 | Process for producing collagen fibres |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0552576B1 (en) |
AT (1) | ATE163447T1 (en) |
DE (1) | DE69224511T2 (en) |
DK (1) | DK0552576T3 (en) |
ES (1) | ES2114924T3 (en) |
FR (1) | FR2686612B1 (en) |
GR (1) | GR3026751T3 (en) |
Cited By (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6361551B1 (en) | 1998-12-11 | 2002-03-26 | C. R. Bard, Inc. | Collagen hemostatic fibers |
US6454787B1 (en) | 1998-12-11 | 2002-09-24 | C. R. Bard, Inc. | Collagen hemostatic foam |
US8263135B2 (en) | 2004-09-09 | 2012-09-11 | Ying Jackie Y | Process for isolating biomaterial from tissue and an isolated biomaterial extract prepared therefrom |
US8932619B2 (en) | 2007-06-27 | 2015-01-13 | Sofradim Production | Dural repair material |
US9308068B2 (en) | 2007-12-03 | 2016-04-12 | Sofradim Production | Implant for parastomal hernia |
US9445883B2 (en) | 2011-12-29 | 2016-09-20 | Sofradim Production | Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit |
US9499927B2 (en) | 2012-09-25 | 2016-11-22 | Sofradim Production | Method for producing a prosthesis for reinforcing the abdominal wall |
US9526603B2 (en) | 2011-09-30 | 2016-12-27 | Covidien Lp | Reversible stiffening of light weight mesh |
US9554887B2 (en) | 2011-03-16 | 2017-01-31 | Sofradim Production | Prosthesis comprising a three-dimensional and openworked knit |
US9622843B2 (en) | 2011-07-13 | 2017-04-18 | Sofradim Production | Umbilical hernia prosthesis |
US9750837B2 (en) | 2012-09-25 | 2017-09-05 | Sofradim Production | Haemostatic patch and method of preparation |
US9839505B2 (en) | 2012-09-25 | 2017-12-12 | Sofradim Production | Prosthesis comprising a mesh and a strengthening means |
US9867909B2 (en) | 2011-09-30 | 2018-01-16 | Sofradim Production | Multilayer implants for delivery of therapeutic agents |
US9877820B2 (en) | 2014-09-29 | 2018-01-30 | Sofradim Production | Textile-based prosthesis for treatment of inguinal hernia |
US9931198B2 (en) | 2015-04-24 | 2018-04-03 | Sofradim Production | Prosthesis for supporting a breast structure |
US9932695B2 (en) | 2014-12-05 | 2018-04-03 | Sofradim Production | Prosthetic porous knit |
US9980802B2 (en) | 2011-07-13 | 2018-05-29 | Sofradim Production | Umbilical hernia prosthesis |
US10070948B2 (en) | 2008-06-27 | 2018-09-11 | Sofradim Production | Biosynthetic implant for soft tissue repair |
US10080639B2 (en) | 2011-12-29 | 2018-09-25 | Sofradim Production | Prosthesis for inguinal hernia |
US10159555B2 (en) | 2012-09-28 | 2018-12-25 | Sofradim Production | Packaging for a hernia repair device |
US10184032B2 (en) | 2015-02-17 | 2019-01-22 | Sofradim Production | Method for preparing a chitosan-based matrix comprising a fiber reinforcement member |
US10213283B2 (en) | 2013-06-07 | 2019-02-26 | Sofradim Production | Textile-based prosthesis for laparoscopic surgery |
US10327882B2 (en) | 2014-09-29 | 2019-06-25 | Sofradim Production | Whale concept—folding mesh for TIPP procedure for inguinal hernia |
US10363690B2 (en) | 2012-08-02 | 2019-07-30 | Sofradim Production | Method for preparing a chitosan-based porous layer |
US10405960B2 (en) | 2013-06-07 | 2019-09-10 | Sofradim Production | Textile-based prothesis for laparoscopic surgery |
US10549015B2 (en) | 2014-09-24 | 2020-02-04 | Sofradim Production | Method for preparing an anti-adhesion barrier film |
US10646321B2 (en) | 2016-01-25 | 2020-05-12 | Sofradim Production | Prosthesis for hernia repair |
US10675137B2 (en) | 2017-05-02 | 2020-06-09 | Sofradim Production | Prosthesis for inguinal hernia repair |
US10682215B2 (en) | 2016-10-21 | 2020-06-16 | Sofradim Production | Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained |
US10743976B2 (en) | 2015-06-19 | 2020-08-18 | Sofradim Production | Synthetic prosthesis comprising a knit and a non porous film and method for forming same |
US10865505B2 (en) | 2009-09-04 | 2020-12-15 | Sofradim Production | Gripping fabric coated with a bioresorbable impenetrable layer |
US11471257B2 (en) | 2018-11-16 | 2022-10-18 | Sofradim Production | Implants suitable for soft tissue repair |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2010009694A (en) * | 2010-09-03 | 2011-03-31 | Luis Miguel Solis Morales | Process for obtaining a collagen-rich extract from the skin of animals and product thus obtained. |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1568829A (en) * | 1967-12-01 | 1969-05-30 | ||
DE1913563A1 (en) * | 1968-03-18 | 1969-10-09 | Unilever Nv | Collagen products |
FR2200377A1 (en) * | 1972-09-18 | 1974-04-19 | Leonard Daniel | |
FR2371475A1 (en) * | 1976-11-22 | 1978-06-16 | Nippi Inc | DISPERSION OF COLLAGEN FIBERS, ITS PREPARATION PROCESS AND ITS APPLICATIONS |
EP0331786A1 (en) * | 1988-03-11 | 1989-09-13 | CHEMOKOL G.b.R. Ing.-Büro für Kollagenprodukte | Method for the preparation of collagen membranes for haemostasis, wound treatment and implants |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU908357A1 (en) * | 1978-09-19 | 1982-02-28 | Московская Ордена Трудового Красного Знамени Ветеринарная Академия Им. К.И.Скрябина | Method of producing collagenic material |
-
1992
- 1992-01-24 FR FR9200739A patent/FR2686612B1/en not_active Expired - Fee Related
- 1992-12-21 AT AT92403501T patent/ATE163447T1/en not_active IP Right Cessation
- 1992-12-21 EP EP92403501A patent/EP0552576B1/en not_active Expired - Lifetime
- 1992-12-21 ES ES92403501T patent/ES2114924T3/en not_active Expired - Lifetime
- 1992-12-21 DK DK92403501T patent/DK0552576T3/en active
- 1992-12-21 DE DE69224511T patent/DE69224511T2/en not_active Expired - Fee Related
-
1998
- 1998-04-29 GR GR980400946T patent/GR3026751T3/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1568829A (en) * | 1967-12-01 | 1969-05-30 | ||
DE1913563A1 (en) * | 1968-03-18 | 1969-10-09 | Unilever Nv | Collagen products |
FR2200377A1 (en) * | 1972-09-18 | 1974-04-19 | Leonard Daniel | |
FR2371475A1 (en) * | 1976-11-22 | 1978-06-16 | Nippi Inc | DISPERSION OF COLLAGEN FIBERS, ITS PREPARATION PROCESS AND ITS APPLICATIONS |
EP0331786A1 (en) * | 1988-03-11 | 1989-09-13 | CHEMOKOL G.b.R. Ing.-Büro für Kollagenprodukte | Method for the preparation of collagen membranes for haemostasis, wound treatment and implants |
Non-Patent Citations (1)
Title |
---|
DATABASE WPIL Section Ch, Week 8251, Derwent Publications Ltd., London, GB; Class A, AN 82-11219J & SU-A-908 357 (MOSC VET ACAD) 28 Février 1982 * |
Cited By (58)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6454787B1 (en) | 1998-12-11 | 2002-09-24 | C. R. Bard, Inc. | Collagen hemostatic foam |
US6361551B1 (en) | 1998-12-11 | 2002-03-26 | C. R. Bard, Inc. | Collagen hemostatic fibers |
US8263135B2 (en) | 2004-09-09 | 2012-09-11 | Ying Jackie Y | Process for isolating biomaterial from tissue and an isolated biomaterial extract prepared therefrom |
US8932619B2 (en) | 2007-06-27 | 2015-01-13 | Sofradim Production | Dural repair material |
US9308068B2 (en) | 2007-12-03 | 2016-04-12 | Sofradim Production | Implant for parastomal hernia |
US10368971B2 (en) | 2007-12-03 | 2019-08-06 | Sofradim Production | Implant for parastomal hernia |
US10070948B2 (en) | 2008-06-27 | 2018-09-11 | Sofradim Production | Biosynthetic implant for soft tissue repair |
US11970798B2 (en) | 2009-09-04 | 2024-04-30 | Sofradim Production | Gripping fabric coated with a bioresorbable impenetrable layer |
US10865505B2 (en) | 2009-09-04 | 2020-12-15 | Sofradim Production | Gripping fabric coated with a bioresorbable impenetrable layer |
US10472750B2 (en) | 2011-03-16 | 2019-11-12 | Sofradim Production | Prosthesis comprising a three-dimensional and openworked knit |
US9554887B2 (en) | 2011-03-16 | 2017-01-31 | Sofradim Production | Prosthesis comprising a three-dimensional and openworked knit |
US11612472B2 (en) | 2011-03-16 | 2023-03-28 | Sofradim Production | Prosthesis comprising a three-dimensional and openworked knit |
US9980802B2 (en) | 2011-07-13 | 2018-05-29 | Sofradim Production | Umbilical hernia prosthesis |
US9622843B2 (en) | 2011-07-13 | 2017-04-18 | Sofradim Production | Umbilical hernia prosthesis |
US10709538B2 (en) | 2011-07-13 | 2020-07-14 | Sofradim Production | Umbilical hernia prosthesis |
US11903807B2 (en) | 2011-07-13 | 2024-02-20 | Sofradim Production | Umbilical hernia prosthesis |
US11039912B2 (en) | 2011-07-13 | 2021-06-22 | Sofradim Production | Umbilical hernia prosthesis |
US9526603B2 (en) | 2011-09-30 | 2016-12-27 | Covidien Lp | Reversible stiffening of light weight mesh |
US9867909B2 (en) | 2011-09-30 | 2018-01-16 | Sofradim Production | Multilayer implants for delivery of therapeutic agents |
US10342652B2 (en) | 2011-12-29 | 2019-07-09 | Sofradim Production | Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit |
US11471256B2 (en) | 2011-12-29 | 2022-10-18 | Sofradim Production | Prosthesis for inguinal hernia |
US11925543B2 (en) | 2011-12-29 | 2024-03-12 | Sofradim Production | Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit |
US11266489B2 (en) | 2011-12-29 | 2022-03-08 | Sofradim Production | Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit |
US10080639B2 (en) | 2011-12-29 | 2018-09-25 | Sofradim Production | Prosthesis for inguinal hernia |
US9445883B2 (en) | 2011-12-29 | 2016-09-20 | Sofradim Production | Barbed prosthetic knit and hernia repair mesh made therefrom as well as process for making said prosthetic knit |
US10363690B2 (en) | 2012-08-02 | 2019-07-30 | Sofradim Production | Method for preparing a chitosan-based porous layer |
US9750837B2 (en) | 2012-09-25 | 2017-09-05 | Sofradim Production | Haemostatic patch and method of preparation |
US9499927B2 (en) | 2012-09-25 | 2016-11-22 | Sofradim Production | Method for producing a prosthesis for reinforcing the abdominal wall |
US9839505B2 (en) | 2012-09-25 | 2017-12-12 | Sofradim Production | Prosthesis comprising a mesh and a strengthening means |
US10159555B2 (en) | 2012-09-28 | 2018-12-25 | Sofradim Production | Packaging for a hernia repair device |
US10405960B2 (en) | 2013-06-07 | 2019-09-10 | Sofradim Production | Textile-based prothesis for laparoscopic surgery |
US11622845B2 (en) | 2013-06-07 | 2023-04-11 | Sofradim Production | Textile-based prothesis for laparoscopic surgery |
US11304790B2 (en) | 2013-06-07 | 2022-04-19 | Sofradim Production | Textile-based prothesis for laparoscopic surgery |
US10213283B2 (en) | 2013-06-07 | 2019-02-26 | Sofradim Production | Textile-based prosthesis for laparoscopic surgery |
US10549015B2 (en) | 2014-09-24 | 2020-02-04 | Sofradim Production | Method for preparing an anti-adhesion barrier film |
US11291536B2 (en) | 2014-09-29 | 2022-04-05 | Sofradim Production | Whale concept-folding mesh for TIPP procedure for inguinal hernia |
US11589974B2 (en) | 2014-09-29 | 2023-02-28 | Sofradim Production | Textile-based prosthesis for treatment of inguinal hernia |
US10327882B2 (en) | 2014-09-29 | 2019-06-25 | Sofradim Production | Whale concept—folding mesh for TIPP procedure for inguinal hernia |
US10653508B2 (en) | 2014-09-29 | 2020-05-19 | Sofradim Production | Textile-based prosthesis for treatment of inguinal hernia |
US9877820B2 (en) | 2014-09-29 | 2018-01-30 | Sofradim Production | Textile-based prosthesis for treatment of inguinal hernia |
US9932695B2 (en) | 2014-12-05 | 2018-04-03 | Sofradim Production | Prosthetic porous knit |
US11713526B2 (en) | 2014-12-05 | 2023-08-01 | Sofradim Production | Prosthetic porous knit |
US10745835B2 (en) | 2014-12-05 | 2020-08-18 | Sofradim Production | Prosthetic porous knit |
US11359313B2 (en) | 2014-12-05 | 2022-06-14 | Sofradim Production | Prosthetic porous knit |
US10815345B2 (en) | 2015-02-17 | 2020-10-27 | Sofradim Production | Method for preparing a chitosan-based matrix comprising a fiber reinforcement member |
US10184032B2 (en) | 2015-02-17 | 2019-01-22 | Sofradim Production | Method for preparing a chitosan-based matrix comprising a fiber reinforcement member |
US11439498B2 (en) | 2015-04-24 | 2022-09-13 | Sofradim Production | Prosthesis for supporting a breast structure |
US9931198B2 (en) | 2015-04-24 | 2018-04-03 | Sofradim Production | Prosthesis for supporting a breast structure |
US10660741B2 (en) | 2015-04-24 | 2020-05-26 | Sofradim Production | Prosthesis for supporting a breast structure |
US10743976B2 (en) | 2015-06-19 | 2020-08-18 | Sofradim Production | Synthetic prosthesis comprising a knit and a non porous film and method for forming same |
US11826242B2 (en) | 2015-06-19 | 2023-11-28 | Sofradim Production | Synthetic prosthesis comprising a knit and a non porous film and method for forming same |
US10646321B2 (en) | 2016-01-25 | 2020-05-12 | Sofradim Production | Prosthesis for hernia repair |
US11389282B2 (en) | 2016-01-25 | 2022-07-19 | Sofradim Production | Prosthesis for hernia repair |
US10682215B2 (en) | 2016-10-21 | 2020-06-16 | Sofradim Production | Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained |
US11696819B2 (en) | 2016-10-21 | 2023-07-11 | Sofradim Production | Method for forming a mesh having a barbed suture attached thereto and the mesh thus obtained |
US11672636B2 (en) | 2017-05-02 | 2023-06-13 | Sofradim Production | Prosthesis for inguinal hernia repair |
US10675137B2 (en) | 2017-05-02 | 2020-06-09 | Sofradim Production | Prosthesis for inguinal hernia repair |
US11471257B2 (en) | 2018-11-16 | 2022-10-18 | Sofradim Production | Implants suitable for soft tissue repair |
Also Published As
Publication number | Publication date |
---|---|
GR3026751T3 (en) | 1998-07-31 |
DE69224511T2 (en) | 1998-10-01 |
EP0552576B1 (en) | 1998-02-25 |
FR2686612A1 (en) | 1993-07-30 |
FR2686612B1 (en) | 1994-04-08 |
DE69224511D1 (en) | 1998-04-02 |
DK0552576T3 (en) | 1998-09-23 |
ATE163447T1 (en) | 1998-03-15 |
ES2114924T3 (en) | 1998-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0552576B1 (en) | Process for producing collagen fibres | |
EP0081440B1 (en) | Process for preparing forms of native or non-crosslinked collagen with a preserved helicoidal structure, in association with mucopolysaccharides, and their use in the cosmetic, pharmaceutical, analytical and other fields | |
AU2003229362B9 (en) | Collagen and method for producing same | |
EP0592586B1 (en) | Use of unpigmented fish skin, particularly from flat fish, as a novel industrial source of collagen, extraction method, and collagen and biomaterial thereby obtained | |
US5093474A (en) | Process for the production of gelatin from fish skins | |
EP1983927B1 (en) | Coatings and biomedical implants formed from keratin biomaterials | |
US6270791B1 (en) | Soluble keratin peptide | |
CA1341376C (en) | Protein concentrate, method of making and method of using for therapeutic purposes, which forms a clot upon interacting with trombin | |
US20030203008A1 (en) | Preparation of collagen | |
FR2470148A1 (en) | PROCESS FOR THE PREPARATION OF SOLUBLE COLLAGEN FIBERS | |
JP2001508301A (en) | Preparation of collagen | |
JP2903182B2 (en) | Collagen, its production method and cosmetics | |
FR2503561A1 (en) | CONTINUOUS FLEXIBLE FILM FOR COSMETIC AND PHARMACEUTICAL USE CONTAINING POLYPEPTIDES | |
Maistrenko et al. | Collagen matrices from leather industry wastes for biomedical application | |
Van Dyke | Keratin | |
AU2005100078B4 (en) | Collagen and method for producing same | |
CA2006238A1 (en) | Process for the production of gelatin from fish skins | |
FR2606638A1 (en) | Method for the enzymatic hydrolysis of gelatins and replacement solutions obtained | |
BG109565A (en) | Multilayer bioresorbable membrane for guided tissue regeneration |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
17P | Request for examination filed |
Effective date: 19930817 |
|
17Q | First examination report despatched |
Effective date: 19950822 |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAG | Despatch of communication of intention to grant |
Free format text: ORIGINAL CODE: EPIDOS AGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAH | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOS IGRA |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19980225 |
|
REF | Corresponds to: |
Ref document number: 163447 Country of ref document: AT Date of ref document: 19980315 Kind code of ref document: T |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: NV Representative=s name: ERNST ACKERMANN PATENTANWALT Ref country code: CH Ref legal event code: EP |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19980226 |
|
REF | Corresponds to: |
Ref document number: 69224511 Country of ref document: DE Date of ref document: 19980402 |
|
ITF | It: translation for a ep patent filed |
Owner name: MODIANO & ASSOCIATI S.R.L. |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FG2A Ref document number: 2114924 Country of ref document: ES Kind code of ref document: T3 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: SC4A Free format text: AVAILABILITY OF NATIONAL TRANSLATION Effective date: 19980313 |
|
REG | Reference to a national code |
Ref country code: IE Ref legal event code: FG4D Free format text: 78966 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: T3 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LU Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981221 Ref country code: IE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981221 Ref country code: GB Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981221 Ref country code: DK Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981221 Ref country code: AT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981221 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: SE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981222 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: LI Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981231 Ref country code: CH Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981231 Ref country code: BE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19981231 |
|
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
BERE | Be: lapsed |
Owner name: S.A. LABORATOIRES FOURNIER Effective date: 19981231 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: PT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990630 Ref country code: MC Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990630 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: NL Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 19990701 |
|
GBPC | Gb: european patent ceased through non-payment of renewal fee |
Effective date: 19981221 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
NLV4 | Nl: lapsed or anulled due to non-payment of the annual fee |
Effective date: 19990701 |
|
REG | Reference to a national code |
Ref country code: PT Ref legal event code: MM4A Free format text: LAPSE DUE TO NON-PAYMENT OF FEES Effective date: 19990630 |
|
REG | Reference to a national code |
Ref country code: DK Ref legal event code: EBP |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: ES Payment date: 20011210 Year of fee payment: 10 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: DE Payment date: 20011212 Year of fee payment: 10 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: ES Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20021223 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: DE Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20030701 |
|
REG | Reference to a national code |
Ref country code: ES Ref legal event code: FD2A Effective date: 20021223 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED. Effective date: 20051221 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20061227 Year of fee payment: 15 |
|
REG | Reference to a national code |
Ref country code: FR Ref legal event code: ST Effective date: 20081020 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: FR Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES Effective date: 20071231 |